These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7537395)

  • 1. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 3. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
    Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
    [No Abstract]   [Full Text] [Related]  

  • 4. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
    Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
    J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses.
    Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF
    Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
    Chen RH; Kadner A; Mitchell RN; Adams DH
    J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The control of hyperacute rejection by genetic engineering of the donor species.
    White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
    Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
    Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
    Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human decay-accelerating factor expressed on rat hearts inhibits leukocyte adhesion.
    Verbakel CA; van Duikeren S; de Bruin RW; Marquet RL; IJzermans JN
    Transpl Int; 2003 Mar; 16(3):168-72. PubMed ID: 12664211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-supporting pig-to-baboon heart xenotransplantation.
    Waterworth PD; Dunning J; Tolan M; Cozzi E; Langford G; Chavez G; White D; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1201-7. PubMed ID: 9883761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.